Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocular manifestations and clinical outcomes in Tubulointerstitial Nephritis and Uveitis Syndrome (TINU).
Uludag Kirimli G, Hassan M, Onghanseng N, Or C, Yasar C, Park S, Akhavanrezayat A, Mobasserian A, Yavari N, Bazojoo V, Khojasteh H, Ghoraba H, Karaca I, Trong Tuong Than N, Zaidi M, Nguyen QD. Uludag Kirimli G, et al. Among authors: khojasteh h. Eye (Lond). 2024 Feb;38(2):349-356. doi: 10.1038/s41433-023-02695-6. Epub 2023 Aug 25. Eye (Lond). 2024. PMID: 37626158
Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes.
Lashay A, Faghihi H, Mirshahi A, Khojasteh H, Khodabande A, Riazi-Esfahani H, Amoli FA, Pour EK, Delrish E. Lashay A, et al. Among authors: khojasteh h. J Ophthalmic Vis Res. 2020 Aug 6;15(3):341-350. doi: 10.18502/jovr.v15i3.7453. eCollection 2020 Jul-Sep. J Ophthalmic Vis Res. 2020. PMID: 32864065 Free PMC article. Review.
Alterations in choroidal vascular parameters following panretinal photocoagulation using enhanced-depth imaging optical coherence tomography in diabetic retinopathy.
Mirshahi A, Fadakar K, Mirshahi R, Khalili Pour E, Ebrahimiadib N, Ghassemi F, Khojasteh H, Bazvand F, Ghods S, Riazi-Esfahani H, Faghihi H. Mirshahi A, et al. Among authors: khojasteh h. Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):459-469. doi: 10.1007/s00417-021-05401-y. Epub 2021 Sep 1. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34468831
Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab.
Ebrahimiadib N, Lashay A, Riazi-Esfahani H, Jamali S, Khodabandeh A, Zarei M, Roohipoor R, Khojasteh H, Bazvand F, Ojani M, Shahabinejad M, Yaseri M, Modjtahedi BS, Davoudi S, Riazi-Esfahani M. Ebrahimiadib N, et al. Among authors: khojasteh h. Ophthalmic Surg Lasers Imaging Retina. 2020 Mar 1;51(3):145-151. doi: 10.3928/23258160-20200228-03. Ophthalmic Surg Lasers Imaging Retina. 2020. PMID: 32211904
Evaluating the Efficacy and Safety of Aflibercept Biosimilar (P041) Compared with Originator Product in Patients with Neovascular Age-Related Macular Degeneration.
Karkhaneh R, Faghihi H, Riazi-Esfahani H, Abrishami M, Bazvand F, Ebrahimiadib N, Johari M, Akhlaghi M, Shoeibi N, Nowroozzadeh MH, Ansari Astaneh MR, Khojasteh H, Imani Fooladi M, Khodabande A, Ghassemi F, Khalili Pour E, Zarei M, Mirshahi A, Fazel F, Ashraf H, Hosseini SM, Dourandeesh M, Feghhi M, Alizadeh Y, Behboudi H, Azadi P, Sabzvari A, Kafi H, Ghasemi Falavarjani K. Karkhaneh R, et al. Among authors: khojasteh h. Ophthalmol Retina. 2024 Aug;8(8):744-753. doi: 10.1016/j.oret.2024.02.012. Epub 2024 Feb 28. Ophthalmol Retina. 2024. PMID: 38428459 Clinical Trial.
63 results